Levobupivacaine 0.5%
Levobupivacaine 0.5% is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks
Transversus Abdominis Plane Block (TAP) for Laparoscopic Cholecystectomy Surgery
Stimulating Catheter for Lumbar Plexus Block: Better Postoperative Analgesia?
Comparison of the Analgesic Effect of Different Local Anesthetics in Interscalene Nerve Block for Shoulder Surgery
Total Knee Prosthesis With Continuous Block of Adductor Canal and Outcome
Clinical Trials (6)
The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks
Transversus Abdominis Plane Block (TAP) for Laparoscopic Cholecystectomy Surgery
Stimulating Catheter for Lumbar Plexus Block: Better Postoperative Analgesia?
Comparison of the Analgesic Effect of Different Local Anesthetics in Interscalene Nerve Block for Shoulder Surgery
Total Knee Prosthesis With Continuous Block of Adductor Canal and Outcome
Intraperitoneal Application of Levobupivacaine During Laparoscopic Surgery in Kids.
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6